Treatment of glaucoma by prostaglandin agonists and beta‐blockers in combination directly reduces pro‐fibrotic gene expression in trabecular meshwork

Prostaglandin analogues (PG), beta‐blockers (BB) or their combination (PG+BB) are used primarily to reduce the intraocular pressure (IOP) pathologically associated with glaucoma. Since, fibrosis of the trabecular meshwork (TM) is a major aetiological factor in glaucoma, we studied the effect of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Tejwani, Sushma, Machiraju, Praveen, Nair, Archana Padmanabhan, Ghosh, Anuprita, Das, Raunak Kumar, Ghosh, Arkasubhra, Sethu, Swaminathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205793/
https://www.ncbi.nlm.nih.gov/pubmed/32267082
http://dx.doi.org/10.1111/jcmm.15172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205793/
https://www.ncbi.nlm.nih.gov/pubmed/32267082
http://dx.doi.org/10.1111/jcmm.15172

Ejemplares similares